CHI CHIN-WEN,LIN HENG-LIANG,LIU TSUNG-YUN,LUI WING-YIU,CHAU GAR-YANG
申请号：
PL35319800
公开号：
PL212612B1
申请日:
2000.08.29
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 muM. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
